zeatin has been researched along with sb 203580 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bi, Z; Chen, W; Ji, C; Kang, J; Wan, Y; Yang, B | 1 |
Bi, Z; Cheng, L; He, S; Ji, C; Shan, S; Su, Z; Sun, W; Wan, Y; Xia, J; Yang, B; Yang, Y; Yu, L | 1 |
2 other study(ies) available for zeatin and sb 203580
Article | Year |
---|---|
Trans-Zeatin inhibits UVB-induced matrix metalloproteinase-1 expression via MAP kinase signaling in human skin fibroblasts.
Topics: Anthracenes; Blotting, Western; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Fibroblasts; Flavonoids; Humans; Imidazoles; Infant, Newborn; MAP Kinase Signaling System; Matrix Metalloproteinase 1; Mitogen-Activated Protein Kinases; Plant Growth Regulators; Pyridines; Skin; Ultraviolet Rays; Zeatin | 2009 |
Trans-Zeatin attenuates ultraviolet induced down-regulation of aquaporin-3 in cultured human skin keratinocytes.
Topics: Aquaporin 3; Cell Line; Cell Membrane Permeability; Cells, Cultured; Down-Regulation; Enzyme Inhibitors; Humans; Imidazoles; Keratinocytes; Mitogen-Activated Protein Kinase Kinases; Pyridines; RNA, Small Interfering; Ultraviolet Rays; Water; Wound Healing; Zeatin | 2010 |